Attenuated serum vasoactive intestinal peptide concentrations are correlated with disease severity of non-traumatic osteonecrosis of femoral head

被引:10
|
作者
Liu, Ming [1 ,2 ]
Zhao, Gan [1 ,3 ]
Wei, Biao-Fang [4 ]
机构
[1] Guangzhou Univ Chinese Med, Guangzhou, Guangdong, Peoples R China
[2] Linyi Peoples Hosp, Dept Pain, Linyi, Shandong, Peoples R China
[3] Linyi Tradit Chinese Med Hosp, Dept Sports Med, Linyi, Shandong, Peoples R China
[4] Linyi Peoples Hosp, Dept Orthoped, Jie Fang Rd East 27, Linyi 276003, Shandong, Peoples R China
关键词
Non-traumatic osteonecrosis of the femoral head; Disease severity; Vasoactive intestinal peptide; VIP; EXPRESSION;
D O I
10.1186/s13018-021-02486-3
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Background and objectiveThe neuropeptide vasoactive intestinal peptide is a 28-amino acid neuropeptide that has been shown to stimulate bone repair and angiogenesis. The purpose of this study was to explore the potential role of serum VIP concentration in osteonecrosis of femoral trauma (ONFH).MethodsOne hundred five patients diagnosed with non-traumatic ONFH and 103 healthy individuals were enrolled in our study. Serum VIP, tumor necrosis factor-alpha (TNF-alpha), interluekin-1 beta (IL-1 beta), and macrophage colony-stimulating factor (M-CSF) levels also were detected using the commercial ELISA kit. Radiographic progression was evaluated using FICAT classification. The clinical severity of ONFH was assessed by visual analog score (VAS) and Harris Hip Score (HHS). Receiver-operating characteristic (ROC) curve was performed to test the potential diagnostic value of VIP in radiographic progression.ResultsThe serum VIP level of patients with non-traumatic ONFH was significantly lower than that of healthy controls. There was no significant difference between the alcohol group, the steroid-induction group, and the idiopathic group. Serum VIP levels were significantly higher in ONFH patients with femoral head pre-collapse stage than collapse stage. Serum VIP levels were significantly lower. FICAT 4 non-traumatic ONFH patients had significantly lower serum concentrations of VIP when compared with FICAT 3 and FICAT 2. Moreover, serum VIP levels were significantly lower in ONFH patients with FICAT 3 than FICAT 2. Serum VIP levels were negatively related to FICAT stage. In addition, serum VIP levels were negatively associated with VAS score and positively associated with HHS score. Last, we found serum VIP levels were negatively associated with serum TNF-alpha and IL-1 beta levels. ROC curve analysis indicated that decreased serum VIP could serve as a decent biomarker with regard to the diagnosis of radiographic progression.ConclusionAttenuated serum VIP concentrations are correlated with disease severity of non-traumatic ONFH. Decreased serum VIP may serve as a potential indicator of non-traumatic ONFH.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Non-traumatic osteonecrosis of femoral head and its association with cardio-vascular disease: a case control study
    Srivastava, S.
    Menon, J.
    Austine, J.
    Ramesh, A.
    Ahuja, S.
    BRITISH JOURNAL OF SURGERY, 2023, 110
  • [32] Serum malondialdehyde and superoxide dismutase levels in patients with non-traumatic osteonecrosis of femoral head: a cross-sectional study
    Zhu, Wen-Xiu
    Zhao, Yong-Heng
    Zhang, Peng
    Ye, Qing-He
    Wei, Biao-Fang
    MOLECULAR & CELLULAR TOXICOLOGY, 2024,
  • [33] Bone scintigraphy for osteonecrosis of the knee in patients with non-traumatic osteonecrosis of the femoral head: comparison with magnetic resonance imaging
    Sakai, T
    Sugano, N
    Nishii, T
    Haraguchi, K
    Yoshikawa, H
    Ohzono, K
    ANNALS OF THE RHEUMATIC DISEASES, 2001, 60 (01) : 14 - 20
  • [34] Analysis of the natural collapse course of non-traumatic osteonecrosis of the femoral head based on the matrix model
    Zhao, Rushun
    Wang, Mengfei
    Hao, Yangquan
    Xu, Peng
    Lu, Chao
    JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH, 2024, 19 (01)
  • [35] Identification and assessment of novel dynamic biomarkers for monitoring non-traumatic osteonecrosis of the femoral head staging
    Jia, Yan
    Zhang, Yanqiong
    Li, Shuwen
    Li, Ruihan
    Li, Weijie
    Li, Taixian
    Wang, Rongtian
    Huang, Guangrui
    He, Haijun
    Lin, Na
    Chen, Weiheng
    CLINICAL AND TRANSLATIONAL MEDICINE, 2023, 13 (06):
  • [36] Risk factors of preoperative deep vein thrombosis in patients with non-traumatic osteonecrosis of the femoral head
    Wu, Dongwei
    Wang, Tianyu
    Li, Chengsi
    Cheng, Xinqun
    Yang, Zhenbang
    Zhu, Yanbin
    Zhang, Yingze
    BMC MUSCULOSKELETAL DISORDERS, 2024, 25 (01)
  • [37] Investigational regenerative medicine for non-traumatic osteonecrosis of the femoral head: a survey of registered clinical trials
    Kuroda, Yutaka
    Kawai, Toshiyuki
    Okuzu, Yaichiro
    Morita, Yugo
    Matsuda, Shuichi
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2024, 33 (04) : 405 - 414
  • [38] Core decompression combined with implantation of a demineralised bone matrix for non-traumatic osteonecrosis of the femoral head
    Helbig, L.
    Simank, H. G.
    Kroeber, M.
    Schmidmaier, G.
    Gruetzner, P. A.
    Guehring, T.
    ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY, 2012, 132 (08) : 1095 - 1103
  • [39] Long-term outcomes of transtrochanteric rotational osteotomy for non-traumatic osteonecrosis of the femoral head
    Morita, D.
    Hasegawa, Y.
    Okura, T.
    Osawa, Y.
    Ishiguro, N.
    BONE & JOINT JOURNAL, 2017, 99B (02): : 175 - 183
  • [40] Analysis of the natural collapse course of non-traumatic osteonecrosis of the femoral head based on the matrix model
    Rushun Zhao
    Mengfei Wang
    Yangquan Hao
    Peng Xu
    Chao Lu
    Journal of Orthopaedic Surgery and Research, 19